$61.99 +0.71 (%) AbbVie Inc - New York Stock Exchange, Inc.

Jan. 13, 2017 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Week in Review: China's Sanpower Pays $820 for Provenge, a Prostate Immunotherapy

    TalkMarkets | Jan. 14, 2017 | 12:58PM EST
  2. Week In Review: China's Sanpower Pays $820M For Provenge, A Prostate Immunotherapy

    TalkMarkets | Jan. 14, 2017 | 12:58PM EST
  3. Healthcare Stocks Could Suffer This Year

    Dividend.com | Jan. 11, 2017 | 08:00AM EST
  4. 10 Stocks For Using A Benjamin Graham Value Investing Strategy – January 2016

    TalkMarkets | Jan. 10, 2017 | 10:06AM EST
  5. AbbVie Leads 3 Other Dividend Aristocrats Going Ex-Dividend This Week

    Dividend.com | Jan. 9, 2017 | 08:00AM EST
  6. My 7 Favorite Dividend Health Care Stocks Today

    TalkMarkets | Jan. 5, 2017 | 16:38PM EST
  7. These 7 Notable Stocks Going Ex-Dividend Next Week

    TalkMarkets | Jan. 4, 2017 | 10:50AM EST
  8. Biotech Blahs: Out Of Favor But Great For Stock Pickers

    TalkMarkets | Jan. 3, 2017 | 02:49AM EST
  9. Which Top 5 Biotech Stocks In 2016 Are Slated For Triple-Digit Gains?

    Investors Business Daily | Dec. 30, 2016 | 12:45PM EST
  10. Which Top 5 Biotech Stocks In 2016 Are Slated For Triple-Digit Gains?

    Investors Business Daily | Dec. 30, 2016 | 12:45PM EST
  11. The 10 Best Dividend Aristocrats for 2017 and Beyond

    TalkMarkets | Dec. 22, 2016 | 17:17PM EST
  12. Bristol-Myers Will Gain In Lung Cancer Square-Off Vs. Merck: Jefferies

    Investors Business Daily | Dec. 19, 2016 | 14:25PM EST
  13. Jefferies Says Sell Merck, Buy Bristol-Myers Heading Into New Year

    TalkMarkets | Dec. 19, 2016 | 12:48PM EST
  14. Gilead Must Pay Merck $2.5 Billion In Hep C Patent Fight; Agios Stock Anemic

    Investors Business Daily | Dec. 15, 2016 | 18:26PM EST
  15. Swing Trading Watch List - Monday, December 12

    TalkMarkets | Dec. 12, 2016 | 23:47PM EST
  16. Biotechs Mixed Hurt By Alexion And Ophthotech

    TalkMarkets | Dec. 12, 2016 | 23:03PM EST
  17. Biotechs Unhinged By Tough Pricing Talk

    TalkMarkets | Dec. 8, 2016 | 23:04PM EST
  18. Actelion Remains In M&A Spotlight, ASH Data In Focus

    TalkMarkets | Dec. 7, 2016 | 18:01PM EST
  19. Dividend Income Update November 2016

    TalkMarkets | Dec. 4, 2016 | 21:02PM EST
  20. Guide to American Funds Investment Company of America R2 Fund (RICBX)

    TalkMarkets | Dec. 4, 2016 | 04:08AM EST
  21. OraSure Stock Sets Up For Buy Point On Hep C Contract, Helix Win

    Investors Business Daily | Dec. 1, 2016 | 16:21PM EST
  22. Market Reversal In Biotech But Healthcare Stocks Are Still Muddled

    TalkMarkets | Nov. 29, 2016 | 22:56PM EST
  23. December 2016 Stock Considerations

    TalkMarkets | Nov. 28, 2016 | 10:06AM EST
  24. Rayno Biobeat #4: Sector Shift Underway But What’s Next For Biotech?

    TalkMarkets | Nov. 23, 2016 | 00:13AM EST
  25. Pfizer: How a 15% Decline is a Gift to Income Investors

    TalkMarkets | Nov. 20, 2016 | 11:12AM EST
  26. Biotech Stocks Soar on Election Results, Gilead HBV Drug Approved

    TalkMarkets | Nov. 16, 2016 | 15:30PM EST
  27. Rayno Biobeat #3…Trump Biotech Rally Leads Market Up

    TalkMarkets | Nov. 9, 2016 | 23:23PM EST
  28. Pharmaceutical Stocks Surge After Republican Victory

    TalkMarkets | Nov. 9, 2016 | 12:48PM EST
  29. On The Fly: Top stock stories for Monday

    TalkMarkets | Nov. 7, 2016 | 18:48PM EST
  30. Rayno Biobeat #2…Good Value in Large Cap Biopharmaceuticals

    TalkMarkets | Nov. 7, 2016 | 10:20AM EST
  31. Before The Move: Stocks To Own If Trump Wins

    TalkMarkets | Nov. 6, 2016 | 16:47PM EST
  32. Dividend Aristocrats In Focus Part 29: Abbott Laboratories

    TalkMarkets | Nov. 3, 2016 | 11:54AM EST
  33. Dividend Aristocrats In Focus Part 28: Abbvie

    TalkMarkets | Nov. 3, 2016 | 10:25AM EST
  34. November 2016 Stock Considerations

    TalkMarkets | Nov. 1, 2016 | 09:38AM EST
  35. Biotech Meltdown: Financial Metrics Offer Few Clues For What is Next

    TalkMarkets | Nov. 1, 2016 | 06:52AM EST
  36. Recent Stock Purchase II October 2016

    TalkMarkets | Oct. 29, 2016 | 11:19AM EST
  37. Hershey Co. Rises On Earnings, AbbVie Inc. Declines On Sales Miss

    TalkMarkets | Oct. 28, 2016 | 10:16AM EST
  38. How to Play Hot Tech IPOs With ETFs

    TalkMarkets | Oct. 21, 2016 | 18:39PM EST
  39. Big Pharma’s Big Biotech Problem

    Dividend.com | Oct. 12, 2016 | 08:00AM EST
  40. Stocks Going Ex Dividend The Second Week Of October

    TalkMarkets | Oct. 9, 2016 | 18:47PM EST
  41. AbbVie Inc. Company Leads 33 Stocks Going Ex-Dividend Next Week

    Dividend.com | Oct. 6, 2016 | 08:00AM EST
  42. Biotech Stocks Recovering From Last Week’s Free Fall

    TalkMarkets | Oct. 5, 2016 | 23:06PM EST
  43. Rayno 2016 Life Science Portfolio Update

    TalkMarkets | Sep. 29, 2016 | 20:14PM EST
  44. Gilead 'Paralyzed' On Likely Hepatitis C Share Loss To AbbVie, Merck

    IBD | Sep. 27, 2016 | 15:28PM EST
  45. Biosimilars In Limelight On FDA Approval Of Amgen Drug

    TalkMarkets | Sep. 27, 2016 | 12:30PM EST
  46. How Will Healthcare Stocks Be Affected If Donald Trump Wins?

    Dividend.com | Sep. 12, 2016 | 11:00AM EST
  47. Don’t Worry, AbbVie Will Be Just Fine

    Dividend.com | Aug. 31, 2016 | 08:00AM EST
  48. Apple, Facebook, Alphabet, Amazon, Ford, McDonald's Headline Busy Week

    Investors Business Daily | Jul. 29, 2016 | 11:13AM EST
  49. Trending on Dividend.com: Technology Stocks Gain Visibility as Earnings Season Is Underway

    Dividend.com | Jul. 29, 2016 | 11:00AM EST
  50. AbbVie, Merck Beat Earnings Estimates, But Sanofi Lags

    Investors Business Daily | Jul. 29, 2016 | 09:46AM EST
Trading Center